Showing 61 - 70 of 96
Persistent link: https://www.econbiz.de/10010707914
Persistent link: https://www.econbiz.de/10010708345
Persistent link: https://www.econbiz.de/10010708362
Persistent link: https://www.econbiz.de/10010708384
Persistent link: https://www.econbiz.de/10010708719
We develop a "welfarist" model in which the collective demand for health insurance is mainly explained by a solvability motive : health insurance does not have for principal function to treat the risk aversion of solvent agents but to make it possible to individuals who are too poor to assume...
Persistent link: https://www.econbiz.de/10010708942
Persistent link: https://www.econbiz.de/10010712474
Aims: To assess the impact of irritable bowel syndrome (IBS) on patient-reported health-related quality of life (HRQOL). Methods: Two HRQOL instruments were administered by telephone interviews to a sample of 253 IBS French patients recruited from the general population. IBS was diagnosed...
Persistent link: https://www.econbiz.de/10011071869
Rationnel Les études médicoéconomiques sont rares dans l'arthrose. Son traitement par acide hyaluronique conduit-il à un surcoût ? Méthodes Étude observationnelle, multicentrique, longitudinale de type « avant–après » évaluant les conséquences médicoéconomiques d'un traitement...
Persistent link: https://www.econbiz.de/10011071956
Docetaxel in combination with the conventional anticancer agents doxorubicin and cyclophosphamide (TAC) has shown better efficacy than 5-fluorouracil (5FU) combined with the same agents (FAC) as adjuvant treatment for women with early breast cancer in a randomised controlled trial (BCIRG001)....
Persistent link: https://www.econbiz.de/10011072001